Orbexcel Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Orbexcel Drugs Private Limited

Orbexcel Drugs Private Limited, a struck off private limited company, was established on 03 June 2011 in Mumbai, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2011PTC218296. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sanjeev Madan Dutta (Director), Bharat Bhushan Datta (Director). Past directors included Suhasini Srivastava, Leena Dutta. Its latest AGM occurred on 25 September 2012, with the balance sheet filed on 31 March 2012. It is based at 4B-802, Phase-Iii Ng, Suncity Thakur Village, Kandivali East, Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2011PTC218296

  • Registration Number

    218296

  • Incorporation Date

    03 June 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2012
Company report

Orbexcel Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orbexcel Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Orbexcel Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjeev Madan Dutta Director 03 Jun 2011 Current
Bharat Bhushan Datta Director 28 Aug 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Aug 2012 Past
Pramod Abcsdd Director 06 Aug 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orbexcel Drugs.

Enhance accessibility to Orbexcel Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Orbexcel Drugs revenue growth over time
Orbexcel Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orbexcel Drugs?

Unlock access to Orbexcel Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Orbexcel Drugs?

Unlock and access historical data on people associated with Orbexcel Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orbexcel Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbexcel Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orbexcel Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Orbexcel Drugs Private Limited last Annual general meeting of members was held on 25 Sep 2012 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Bharat Bhushan Datta was appointed as a Director was appointed as a Director on 28 Aug 2012 & has been associated with this company since 13 years 5 months . was documented.

  • Balance Sheet

    The activity Orbexcel Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Mumbai. was completed.

  • Director Appointment

    Sanjeev Madan Dutta was appointed as a Director was appointed as a Director on 03 Jun 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.

  • Company Incorporation

    The activity Orbexcel Drugs Private Limited was registered on 03 Jun 2011 with Roc Mumbai & aged 14 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Orbexcel Drugs Private Limited?

The CIN of Orbexcel Drugs Private Limited is U24100MH2011PTC218296.

Where is Orbexcel Drugs Private Limited headquartered?

Orbexcel Drugs Private Limited is headquartered at 4B-802, Phase-Iii Ng, Suncity Thakur Village, Kandivali East, Mumbai, Maharashtra, 400101.

When was Orbexcel Drugs Private Limited incorporated?

Orbexcel Drugs Private Limited was incorporated on 03 June 2011.

Who are the current directors of Orbexcel Drugs Private Limited?

The current directors of Orbexcel Drugs Private Limited are

What is the primary industry of Orbexcel Drugs Private Limited?

The primary industry of Orbexcel Drugs Private Limited is Chemicals.

Is Orbexcel Drugs Private Limited a listed company?

Orbexcel Drugs Private Limited is unlisted.

What is the capital structure of Orbexcel Drugs Private Limited?

The authorized capital of Orbexcel Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available